Balneo and PRM Research Journal, Journal Year: 2024, Volume and Issue: 15(Vol.15, no. 2), P. 683 - 683

Published: June 21, 2024

Introduction. Heart failure, with its economic and social burden increasing incidence in the general population, is a global problem. Since 2015, new class of drugs angiotensin neprilysin re-ceptor inhibitory action, namely combination sacubitril valsartan (S/V), has been introduced treatment HF. The study aimed to perform bibliometric analysis available knowledge assess research trends through quantitative literature related use S/V physical training Methods. In study, we used Web Science database, period 2015-January 2024. data obtained was processed Vos viewer Microsoft Excel. results their interpretation provided an overview most relevant prolific journals, countries, authors, organizations. Conclusion. After marketing approval, publication trend upward until 2023, when number publica-tions decreased significantly. Our shows that although publications de-creased, updates guidelines were published, significant articles supporting benefits chronic HF (with reduced or preserved ejection frac-tion) but also acute forms published. Although on cardiac rehabilitation low, this highlighted studies have emerged assessing reasons why patients do not follow programme. Cardiac important for physiological benefits: improving VO2max, myocardial blood flow endothelial function. Health policies should be put place raise awareness importance rehabilitation, including distances centre. Keywords: sacubitril/valsartan; heart failure; rehabilitation;

Language: Английский